Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferric hydroxide is an inorganic compound used primarily as an iron supplement for the treatment and prevention of iron deficiency anemia. It acts as a source of elemental iron in various pharmaceutical formulations. Upon administration—often intravenously or intramuscularly in complexed forms such as with dextran or sucrose—ferric hydroxide is processed by the reticuloendothelial system to release bioavailable iron that replenishes hemoglobin and restores depleted body stores. It is indicated especially for patients with chronic kidney disease who require parenteral iron therapy[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferric hydroxide.